|
|
DEA Investigation of Express Scripts Drug Diversion, Regulatory Violations Leads to $2.75 Million Settlement May 17 (Philadelphia, PA) - Express Scripts, Inc. and Express Scripts Pharmacy Services, Inc. (“ESI”) today agreed to pay to the government $ 2.75 million to settle the case against the companies. DEA Philadelphia Diversion Group 1 inspected company locations in Pennsylvania and discovered numerous instances of drug diversion and regulatory violations. The settlement covers conduct from 2002 through 2009. The matter was handled by the US Attorney’s Office for the Eastern District of Pennsylvania. >> Full Story
|
|
||||||||||||||||||||||||
